AngioDynamics, Inc. (NASDAQ: ANGO) shares fell about 21% to $11.16 Thursday morning, even though the company’s fiscal first-quarter results beat estimates. Revenue rose 6.9% to…
October 08, 2026
September 30, 2026
Blood Cancer Awareness Month: The Next Wave of Treatments Is Moving Deeper Into the Biology of Disease
From protein degradation and menin inhibition to targeted radiopharmaceuticals and off-the-shelf cell treatments, companies are testing new ways to treat blood cancers and overcome resistance….
September 21, 2026
QinFlow Launches PressSure™, Targeting One of Critical Care’s Most Persistent Manual Tasks
QinFlow (Private — no public ticker) rolls out a battery-powered pressure management device for blood and IV fluid delivery PLANO, Texas — September 21,…
Conexeu Sciences (NASDAQ: CNXU) stock is getting a lift as the company checks off key steps toward bringing its lead wound care device, CXU, into the…
March 16, 2026
Boston Scientific Secures Strategic Manufacturing License to Lead China’s Medtech Market
Boston Scientific Corporation (NYSE: BSX) is currently expanding its global footprint by securing a landmark manufacturing license in the Chinese market. This strategic achievement allows…
February 12, 2026
Encora Therapeutics Gains FDA Clearance for Essential Tremor Device
Encora Therapeutics has secured U.S. Food and Drug Administration (FDA) clearance for its Encora X1 neurostimulation wearable, positioning the company to enter the growing market…